Skip to main content

Home/ Health and fitness/ Group items tagged #Digital_Health

Rss Feed Group items tagged

Filter: All | Bookmarks | Topics Simple Middle
jacob logan

ESMO 2019: Ovarian cancer drug fails to meet primary endpoint in study - 1 views

www.clinicaltrialsarena.com/...esmo-immunogen

#ESMO_2019 #ESMO_Conference_2019 #ESMO_Congress_2019 #Digital_Health #ESMO_2019_Meeting

shared by jacob logan on 10 Oct 19 - No Cached
  • jacob logan on 10 Oct 19
     
    ImmunoGen has presented full data from the Phase III Forward I study of mirvetuximab soravtansine in ovarian cancer at the European Society for Medical Oncology (ESMO) 2019 Congress in Barcelona, Spain, saying that it failed to meet the primary endpoint of progression-free survival (PFS).
1 - 1 of 1
Showing 20▼ items per page